TrialThe Journal of antimicrobial chemotherapy2018

Antimicrobial susceptibility and ribotypes of Clostridium difficile isolates from a Phase 2 clinical trial of ridinilazole (SMT19969) and vancomycin.

David R Snydman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.